Ag Novartis, 10% Owner at Ra Pharmaceuticals, Inc. (RARX), sold 168,481 shares at $20.93 ($3.5M) on 2017-02-24, disclosed to the SEC on 2017-05-02.
Open-market sale of $3.5M RARX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.86 | 749 | $16K | 0.5% |
| 2 | $21.04 | 4,999 | $105K | 3.0% |
| 3 | $21.04 | 4,999 | $105K | 3.0% |
| 4 | $20.93 | 5,398 | $113K | 3.2% |
| 5 | $20.93 | 5,398 | $113K | 3.2% |
| 6 | $20.96 | 57,844 |
| $1.2M |
| 34.3% |
| 7 | $20.96 | 57,844 | $1.2M | 34.3% |
| 8 | $20.86 | 7,847 | $164K | 4.6% |
| 9 | $20.86 | 7,847 | $164K | 4.6% |
| 10 | $20.91 | 7,778 | $163K | 4.6% |
| 11 | $20.91 | 7,778 | $163K | 4.6% |
| Total | $20.95 avg | 168,481 | $3.5M | 100% |
| Filing → |
| GRTX | SELL | 2020-06-12 | $242K | — | Filing → |
| GRTX | BUY | 2019-11-12 | $3.0M | — | Filing → |
| ARPO | SELL | 2019-04-29 | $1.4M | — | Filing → |